
Mohammed Tawil Drives Pharma Innovation in the Chinese Mainland
Mohammed Tawil leads Boehringer Ingelheim’s operations in the Chinese mainland, aiming for groundbreaking treatments and a global talent drive by 2030.
Stay informed, stay connected—news for amigos everywhere.
Mohammed Tawil leads Boehringer Ingelheim’s operations in the Chinese mainland, aiming for groundbreaking treatments and a global talent drive by 2030.
China’s vast talent pool is set to drive AI development, says WEF’s Jeremy Jurgens.